Coniferaldehyde attenuates Alzheimer's pathology via activation of Nrf2 and its targets

Background: Alzheimer's disease (AD) currently lacks a cure. Because substantial neuronal damage usually occurs before AD is advanced enough for diagnosis, the best hope for disease-modifying AD therapies likely relies on early intervention or even prevention, and targeting multiple pathways im...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Yaqiong, Stewart, Tessandra, Bai, Lidan, Li, Xue, Xu, Ting, Iliff, Jeffrey, Shi, Min, Zheng, Danfeng, Yuan, Lan, Wei, Taotao, Yang, Xiaoda, Zhang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929631/
https://www.ncbi.nlm.nih.gov/pubmed/31903114
http://dx.doi.org/10.7150/thno.36722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929631/
https://www.ncbi.nlm.nih.gov/pubmed/31903114
http://dx.doi.org/10.7150/thno.36722

Ejemplares similares